EASYWELL BIOMEDICALS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.6 TWD | -4.65% |
|
-3.64% | +54.00% |
| Sales 2022 | 179M 5.5M | Sales 2023 | 272M 8.35M | Capitalization | 4.79B 147M |
|---|---|---|---|---|---|
| Net income 2022 | -161M -4.95M | Net income 2023 | -145M -4.46M | EV / Sales 2022 | 10.3 x |
| Net Debt 2022 | 10.42M 320K | Net Debt 2023 | 38.31M 1.18M | EV / Sales 2023 | 17.8 x |
| P/E ratio 2022 |
-11.4
x | P/E ratio 2023 |
-32.6
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 43.58% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.65% | ||
| 1 week | -3.64% | ||
| Current month | -8.49% | ||
| 1 month | +6.53% | ||
| 3 months | +60.00% | ||
| 6 months | +124.73% | ||
| Current year | +54.00% |
1 week
62.50
67.50
1 month
59.1071.40
Current year
38.8071.40
1 year
19.1071.40
3 years
13.3171.40
5 years
10.9071.40
10 years
10.9080.14
| Managers | Title | Age | Since |
|---|---|---|---|
Ai Ping Lee
CEO | Chief Executive Officer | - | 14-08-31 |
Hsueh Chun Wu
DFI | Director of Finance/CFO | - | - |
Howard Lee
BRD | Director/Board Member | 62 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jy Gang Ger
BRD | Director/Board Member | - | 16-06-22 |
Chih Cheng Chang
BRD | Director/Board Member | - | 13-10-24 |
Han Fei Lin
CHM | Chairman | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 63.6 | -4.65% | 105,453 |
| 24-04-18 | 66.7 | -0.45% | 60,152 |
| 24-04-17 | 67 | +2.45% | 87,734 |
| 24-04-16 | 65.4 | -2.97% | 67,580 |
| 24-04-15 | 67.4 | +2.12% | 81,085 |
End-of-day quote Taipei Exchange, April 18, 2024
More quotes
Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +54.00% | 250M | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- 1799 Stock
